Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Hyperforin and Miquelianin from St. John's Wort Attenuate Gene Expression in Neuronal Cells After Dexamethasone-Induced Stress.

Verjee S, Weston A, Kolb C, Kalbhenn-Aziz H, Butterweck V.

Planta Med. 2018 Jul;84(9-10):696-703. doi: 10.1055/a-0581-5286. Epub 2018 Mar 2.

PMID:
29499586
2.

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.

3.

Common variants in GRIK4 and major depressive disorder: An association study in the Chinese Han population.

Ren D, Bi Y, Xu F, Niu W, Zhang R, Hu J, Guo Z, Wu X, Cao Y, Huang X, Yang F, Wang L, Li W, Xu Y, He L, Yu T, He G, Li X.

Neurosci Lett. 2017 Jul 13;653:239-243. doi: 10.1016/j.neulet.2017.05.071. Epub 2017 Jun 2.

PMID:
28583584
4.

Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Lett TA, Walter H, Brandl EJ.

CNS Drugs. 2016 Dec;30(12):1169-1189. Review.

PMID:
27752945
5.

Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

de Sousa RT, Loch AA, Carvalho AF, Brunoni AR, Haddad MR, Henter ID, Zarate CA, Machado-Vieira R.

Neuropsychopharmacology. 2017 Mar;42(4):787-800. doi: 10.1038/npp.2016.149. Epub 2016 Aug 11. Review.

6.

Influence of GRIK4 genetic variants on the electroconvulsive therapy response.

Minelli A, Congiu C, Ventriglia M, Bortolomasi M, Bonvicini C, Abate M, Sartori R, Gainelli G, Gennarelli M.

Neurosci Lett. 2016 Jul 28;626:94-8. doi: 10.1016/j.neulet.2016.05.030. Epub 2016 May 17.

PMID:
27222927
7.

Increased Dosage of High-Affinity Kainate Receptor Gene grik4 Alters Synaptic Transmission and Reproduces Autism Spectrum Disorders Features.

Aller MI, Pecoraro V, Paternain AV, Canals S, Lerma J.

J Neurosci. 2015 Oct 7;35(40):13619-28. doi: 10.1523/JNEUROSCI.2217-15.2015.

8.

The role of GRIK4 gene in treatment-resistant depression.

Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli G, Gennarelli M, Minelli A.

Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142.

PMID:
26139080
9.

GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.

Kawaguchi DM, Glatt SJ.

Pharmacogenomics. 2014 Aug;15(11):1451-9. doi: 10.2217/pgs.14.96.

10.

Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.

Pu M, Zhang Z, Xu Z, Shi Y, Geng L, Yuan Y, Zhang X, Reynolds GP.

Pharmacogenomics. 2013 Feb;14(3):277-88. doi: 10.2217/pgs.13.1.

PMID:
23394390
11.

European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.

Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2012 Jul;22(7):453-68. doi: 10.1016/j.euroneuro.2012.02.006. Epub 2012 Mar 30. Review.

PMID:
22464339
12.

Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.

Serretti A, Chiesa A, Crisafulli C, Massat I, Linotte S, Calati R, Kasper S, Bailer U, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J.

Neuropsychobiology. 2012;65(2):70-5. doi: 10.1159/000329553. Epub 2012 Jan 5.

PMID:
22222462
13.

Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.

Perlis RH, Fijal B, Dharia S, Heinloth AN, Houston JP.

Biol Psychiatry. 2010 Jun 1;67(11):1110-3. doi: 10.1016/j.biopsych.2009.12.010. Epub 2010 Jan 27.

PMID:
20110084
14.

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, Müller-Myhsok B, Holsboer F, Binder EB.

Neuropsychopharmacology. 2010 Feb;35(3):727-40. doi: 10.1038/npp.2009.180. Epub 2009 Nov 18.

15.

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

Laje G, Perlis RH, Rush AJ, McMahon FJ.

Psychiatr Serv. 2009 Nov;60(11):1446-57. doi: 10.1176/appi.ps.60.11.1446.

16.

The genetics of bipolar disorder.

Barnett JH, Smoller JW.

Neuroscience. 2009 Nov 24;164(1):331-43. doi: 10.1016/j.neuroscience.2009.03.080. Epub 2009 Apr 7. Review.

17.
18.

Genetic variation in GRIK4 and the implications for antidepressant treatment.

Paddock S.

Pharmacogenomics. 2008 Feb;9(2):133-5. doi: 10.2217/14622416.9.2.133. No abstract available.

19.

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ.

Am J Psychiatry. 2007 Aug;164(8):1181-8.

PMID:
17671280
20.

Keeping our depressed patients in the right treatment long enough for them to get better: some hopeful findings.

Badaracco MA.

Am J Psychiatry. 2007 Aug;164(8):1136-9. No abstract available.

PMID:
17671271

Supplemental Content

Loading ...
Support Center